336 related articles for article (PubMed ID: 10843678)
41. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
[TBL] [Abstract][Full Text] [Related]
42. Preferential positive selection of T lymphocytes which express two different TCR alpha chains, an endogenous and a transgenic.
Munthe LA; Sollien A; Dembic Z; Bogen B
Scand J Immunol; 1995 Dec; 42(6):651-61. PubMed ID: 8552989
[TBL] [Abstract][Full Text] [Related]
43. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
[TBL] [Abstract][Full Text] [Related]
44. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
Barndt R; Dai MF; Zhuang Y
J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
[TBL] [Abstract][Full Text] [Related]
45. Disrupted development of thymocytes expressing a transgenic TCR upon CD4 overexpression.
Davis CB; Littman DR
Int Immunol; 1995 Dec; 7(12):1977-86. PubMed ID: 8746567
[TBL] [Abstract][Full Text] [Related]
46. Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.
Lacorazza HD; Tucek-Szabo C; Vasović LV; Remus K; Nikolich-Zugich J
J Immunol; 2001 Mar; 166(5):3184-93. PubMed ID: 11207271
[TBL] [Abstract][Full Text] [Related]
47. Thymic selection events mediated by the pre-TCR do not depend upon a limiting ligand.
Dillon SR; Fink PJ
Int Immunol; 1995 Aug; 7(8):1363-73. PubMed ID: 7495743
[TBL] [Abstract][Full Text] [Related]
48. The transient expression of C-C chemokine receptor 8 in thymus identifies a thymocyte subset committed to become CD4+ single-positive T cells.
Kremer L; Carramolino L; Goya I; Zaballos A; Gutiérrez J; Moreno-Ortiz M del C; Martínez-A C; Márquez G
J Immunol; 2001 Jan; 166(1):218-25. PubMed ID: 11123295
[TBL] [Abstract][Full Text] [Related]
49. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
50. In vitro positive selection of alpha beta TCR transgenic thymocytes by a conditionally immortalized cortical epithelial clone.
Tanaka Y; Williams O; Tarazona R; Wack A; Norton T; Kioussis D
Int Immunol; 1997 Mar; 9(3):381-93. PubMed ID: 9088977
[TBL] [Abstract][Full Text] [Related]
51. The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla.
Stephen TL; Tikhonova A; Riberdy JM; Laufer TM
J Immunol; 2009 Nov; 183(9):5554-62. PubMed ID: 19843939
[TBL] [Abstract][Full Text] [Related]
52. Evidence for down-regulation of highly expressed TCR by CD4 and CD45 on non-selected CD4+CD8+ thymocytes.
Sato T; Hozumi K; Kishihara K; Kametani Y; Sato C; Kumagai Y; Mak TW; Habu S
Int Immunol; 1996 Oct; 8(10):1529-35. PubMed ID: 8921432
[TBL] [Abstract][Full Text] [Related]
53. The level of CD4 surface protein influences T cell selection in the thymus.
Frank GD; Parnes JR
J Immunol; 1998 Jan; 160(2):634-42. PubMed ID: 9551897
[TBL] [Abstract][Full Text] [Related]
54. On the role of high- and low-abundance class II MHC-peptide complexes in the thymic positive selection of CD4(+) T cells.
Chmielowski B; Muranski P; Kisielow P; Ignatowicz L
Int Immunol; 2000 Jan; 12(1):67-72. PubMed ID: 10607751
[TBL] [Abstract][Full Text] [Related]
55. Alpha beta lineage-committed thymocytes can be rescued by the gamma delta T cell receptor (TCR) in the absence of TCR beta chain.
Livák F; Wilson A; MacDonald HR; Schatz DG
Eur J Immunol; 1997 Nov; 27(11):2948-58. PubMed ID: 9394823
[TBL] [Abstract][Full Text] [Related]
56. T cell receptor revision does not solely target recent thymic emigrants.
Cooper CJ; Orr MT; McMahan CJ; Fink PJ
J Immunol; 2003 Jul; 171(1):226-33. PubMed ID: 12817002
[TBL] [Abstract][Full Text] [Related]
57. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
58. T cell development in mice expressing CD1d directed by a classical MHC class II promoter.
Forestier C; Park SH; Wei D; Benlagha K; Teyton L; Bendelac A
J Immunol; 2003 Oct; 171(8):4096-104. PubMed ID: 14530331
[TBL] [Abstract][Full Text] [Related]
59. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
Jhaver KG; Chandler P; Simpson E; Mellor AL
J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
[TBL] [Abstract][Full Text] [Related]
60. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions.
Desbarats J; Lapp WS
J Exp Med; 1993 Sep; 178(3):805-14. PubMed ID: 8394404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
